Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Enhance MD

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Enhance MD head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 11 · Grade B

Enhance MD

Visit Enhance MD Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 85 on our six-factor Brief Score — One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

That doesn't make Enhance MD a bad call — it's best for readers who want to see the whole price ladder before they commit and value dose-flat billing plus routine lab work — and who don't need brand-name or oral options. Weigh the six factors below against your own priorities before you decide.

Why CoreAge Rx leads: it's our #1 here — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
86
Supply Reliability
95
84
Transparency
90
88
Access Breadth
93
80
Clinical Oversight
92
87
Track Record
88
82
CoreAge RxBrief Score 94 · 85Enhance MD

Price, coverage & the tracker

CoreAge RxEnhance MD
Brief Score94/100 (A)85/100 (B)
Semaglutide$99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not published$249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay
Tirzepatide$149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not published$329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay
CoverageUS only; restrictions by state, confirmed at intakeNot publicly listed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableStableprice stable

CoreAge Rx: Headline unchanged for a third straight cycle. The $99 and $149 are the 12-month prepay rates; CoreAge publishes no month-to-month price.

Enhance MD: The ladder is fully published, but its rungs are prepay blocks: $212 and $280 are the 12-MONTH rates, while month-to-month is $249 and $329 — and every plan bills every 4 weeks, so a "monthly" plan is 13 charges a year. The $112 is $212 less a dated SUMMER50 coupon, not an entry rate.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.